Your browser doesn't support javascript.
loading
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST.
Vogsen, Marianne; Bülow, Jakob Lykke; Ljungstrøm, Lasse; Oltmann, Hjalte Rasmus; Alamdari, Tural Asgharzadeh; Naghavi-Behzad, Mohammad; Braad, Poul-Erik; Gerke, Oke; Hildebrandt, Malene Grubbe.
Afiliación
  • Vogsen M; Department of Nuclear Medicine, Odense University Hospital, DK-5000 Odense, Denmark.
  • Bülow JL; Department of Oncology, Odense University Hospital, DK-5000 Odense, Denmark.
  • Ljungstrøm L; Department of Clinical Research, University of Southern Denmark, DK-5000 Odense, Denmark.
  • Oltmann HR; Open Patient Data Explorative Network, Odense University Hospital, DK-5000 Odense, Denmark.
  • Alamdari TA; Centre for Personalized Response Monitoring in Oncology, Odense University Hospital, DK-5000 Odense, Denmark.
  • Naghavi-Behzad M; Department of Nuclear Medicine, Odense University Hospital, DK-5000 Odense, Denmark.
  • Braad PE; Department of Clinical Research, University of Southern Denmark, DK-5000 Odense, Denmark.
  • Gerke O; Department of Nuclear Medicine, Odense University Hospital, DK-5000 Odense, Denmark.
  • Hildebrandt MG; Department of Clinical Research, University of Southern Denmark, DK-5000 Odense, Denmark.
Diagnostics (Basel) ; 11(4)2021 Apr 19.
Article en En | MEDLINE | ID: mdl-33921580
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Diagnostics (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Diagnostics (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca